By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics company InDevR will use a $3 million grant from the National Institute of Allergy and Infectious Diseases to develop microarray tools based on technology it licensed from the University of Colorado, Boulder, the firm said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.